Gene · 6375
Papers2,385
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,385
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatics analysis of prognostic value and immune cell infiltration of SERPINA1 gene in cutaneous melanoma. | Ann Transl Med | 2022 | 36267715 | PubTator, text mining | PubMed |
| Beyond eNOS: Genetic influence in NO pathway affecting drug response. | Genet Mol Biol | 2022 | 36264109 | PubTator, text mining | PubMed |
| Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis. | Front Immunol | 2022 | 36263054 | PubTator, text mining | PubMed |
| Study on the prognosis, immune and drug resistance of m6A-related genes in lung cancer. | BMC Bioinformatics | 2022 | 36261786 | PubTator, text mining | PubMed |
| Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant. | Cell Rep Med | 2022 | 36260981 | PubTator, text mining | PubMed |
| Structural and thermodynamic analyses of the β-to-α transformation in RfaH reveal principles of fold-switching proteins. | Elife | 2022 | 36255050 | PubTator, text mining | PubMed |
| Tensile strain and altered synovial tissue metabolism in human knee osteoarthritis. | Sci Rep | 2022 | 36253398 | PubTator, text mining | PubMed |
| Identification pyroptosis-related gene signature to predict prognosis and associated regulation axis in colon cancer. | Front Pharmacol | 2022 | 36249755 | PubTator, text mining | PubMed |
| Pan-cancer analysis of AIM2 inflammasomes with potential implications for immunotherapy in human cancer: A bulk omics research and single cell sequencing validation. | Front Immunol | 2022 | 36248785 | PubTator, text mining | PubMed |
| The soldiers needed to be awakened: Tumor-infiltrating immune cells. | Front Genet | 2022 | 36246629 | PubTator, text mining | PubMed |
| Single-cell transcriptome profiling reveals the key role of ZNF683 in natural killer cell exhaustion in multiple myeloma. | Clin Transl Med | 2022 | 36245253 | PubTator, text mining | PubMed |
| Lipid Metabolism in Cartilage Development, Degeneration, and Regeneration. | Nutrients | 2022 | 36235637 | PubTator, text mining | PubMed |
| Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity. | Cells | 2022 | 36231109 | PubTator, text mining | PubMed |
| Dendritic Cells: The Long and Evolving Road towards Successful Targetability in Cancer. | Cells | 2022 | 36230990 | PubTator, text mining | PubMed |
| Neomorphic DNA-binding enables tumor-specific therapeutic gene expression in fusion-addicted childhood sarcoma. | Mol Cancer | 2022 | 36229873 | PubTator, text mining | PubMed |
| Conducive target range of breast cancer: Hypoxic tumor microenvironment. | Front Oncol | 2022 | 36226050 | PubTator, text mining | PubMed |
| Prognostic value of TIGIT in East Asian patients with solid cancers: A systematic review, meta-analysis and pancancer analysis. | Front Immunol | 2022 | 36211383 | PubTator, text mining | PubMed |
| Identification of distinct functional thymic programming of fetal and pediatric human γδ thymocytes via single-cell analysis. | Nat Commun | 2022 | 36195611 | PubTator, text mining | PubMed |
| Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows. | World J Gastrointest Oncol | 2022 | 36187401 | PubTator, text mining | PubMed |
| The impact of self-compassionate mindfulness on online learning behavioral engagement of international students during COVID-19: Positive emotion and self-improvement motivation as mediators. | Front Psychol | 2022 | 36186329 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6375/papers?page=34